iridium radioisotopes has been researched along with Cancer of Oropharnyx in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (30.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 1 (10.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoffstetter, S | 1 |
Friedrich, RE; Hellner, D; Heyer, D; Krüll, A; Plambeck, K; Schmelzle, R; Schwarz, R | 1 |
Aletti, P; Allavena, C; Bey, P; Hoffstetter, S; Kozminski, P; Luporsi, E; Malissard, L; Peiffert, D; Pernot, M | 1 |
Friedrich, RE; Krüll, A; Plambeck, K; Schmelzle, R; Schwarz, R; Thurmann, H | 1 |
Dische, S; Goodchild, K; Hoskin, P; Pigott, K; Powell, M; Saunders, M | 1 |
Brunner, T; Grabenbauer, GG; Iro, H; Müller, RG; Rödel, C; Sauer, R; Schulze-Mosgau, S; Strnad, V | 1 |
Weidenbecher, W | 1 |
Hoffstetter, S; Langlois, D; Pernot, M | 1 |
Hoffstetter, S; Langlois, D; Malissard, L; Pernot, M; Taghian, A | 1 |
Baillet, F; Crook, J; Langlois, D; Martin, M; Mazeron, JJ; Peynègre, R; Pierquin, B; Raynal, M | 1 |
1 review(s) available for iridium radioisotopes and Cancer of Oropharnyx
Article | Year |
---|---|
[ORL brachytherapy. Brachytherapy of squamous cell carcinoma of the oropharynx].
Topics: Brachytherapy; Carcinoma, Squamous Cell; Contraindications; Dose-Response Relationship, Radiation; Humans; Iridium Radioisotopes; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Prognosis; Radiotherapy Dosage | 1995 |
1 trial(s) available for iridium radioisotopes and Cancer of Oropharnyx
Article | Year |
---|---|
Influence of tumoral, radiobiological, and general factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation+brachytherapy or brachytherapy alone)
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Oropharyngeal Neoplasms; Palatal Neoplasms; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Tonsillar Neoplasms | 1994 |
8 other study(ies) available for iridium radioisotopes and Cancer of Oropharnyx
Article | Year |
---|---|
Interstitial high-dose rate brachytherapy with iridium-192 in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Radiotherapy, High-Energy; Survival Rate; Treatment Outcome | 1995 |
[Salvage therapy of advanced squamous cell carcinoma of the mouth cavity and oropharynx. Results of interstitial high-dose-rate brachytherapy combined with ablative tumor surgery].
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Oropharyngeal Neoplasms; Radiotherapy Dosage; Retrospective Studies; Salvage Therapy; Time Factors | 1997 |
A feasibility study of continuous hyperfractionated accelerated radiotherapy (CHART) and brachytherapy in patients with early oral or oropharyngeal carcinomas.
Topics: Adult; Aged; Brachytherapy; Cesium Radioisotopes; Dose Fractionation, Radiation; Feasibility Studies; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Life Tables; Lymph Nodes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Prospective Studies; Radiation Injuries; Radiopharmaceuticals; Radiotherapy Dosage; Stomatitis; Survival Rate; Time Factors | 1999 |
Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx. Review of 318 patients treated between 1985 and 1997.
Topics: Brachytherapy; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Radiography; Radiotherapy Dosage; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate | 2001 |
[Principles of the treatment of malignant tumors of the oropharynx in the ORL Disease Clinic in Erlangen].
Topics: Antineoplastic Agents; Brachytherapy; Cobalt Radioisotopes; Germany, West; Humans; Iridium Radioisotopes; Neoplasm Staging; Oropharyngeal Neoplasms; Oropharynx; Pharyngectomy | 1990 |
Selection of patients for re-irradiation with local implants in carcinomas of oropharynx and tongue.
Topics: Adult; Aged; Brachytherapy; Humans; Iridium Radioisotopes; Middle Aged; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Tongue Neoplasms | 1988 |
Salvage irradiation of oropharynx and mobile tongue about 192 iridium brachytherapy in Centre Alexis Vautrin.
Topics: Brachytherapy; Humans; Iridium Radioisotopes; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pharyngeal Neoplasms; Prognosis; Radiotherapy; Tongue Neoplasms | 1988 |
[Salvage irradiation of epidermoid carcinoma of the oropharynx by iridium 192].
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma, Squamous Cell; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Pharyngeal Neoplasms | 1987 |